142 related articles for article (PubMed ID: 35984840)
1. DSCN: Double-target selection guided by CRISPR screening and network.
Liu E; Wu X; Wang L; Huo Y; Wu H; Li L; Cheng L
PLoS Comput Biol; 2022 Aug; 18(8):e1009421. PubMed ID: 35984840
[TBL] [Abstract][Full Text] [Related]
2. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
[TBL] [Abstract][Full Text] [Related]
3. Screening drug target combinations in disease-related molecular networks.
Luo M; Jiao J; Wang R
BMC Bioinformatics; 2019 May; 20(Suppl 7):198. PubMed ID: 31074386
[TBL] [Abstract][Full Text] [Related]
4. Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles.
Li X; Xu Y; Cui H; Huang T; Wang D; Lian B; Li W; Qin G; Chen L; Xie L
Artif Intell Med; 2017 Nov; 83():35-43. PubMed ID: 28583437
[TBL] [Abstract][Full Text] [Related]
5. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
6. SL
Liu Y; Wu M; Liu C; Li XL; Zheng J
IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
[TBL] [Abstract][Full Text] [Related]
7. Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.
Tang J; Karhinen L; Xu T; Szwajda A; Yadav B; Wennerberg K; Aittokallio T
PLoS Comput Biol; 2013; 9(9):e1003226. PubMed ID: 24068907
[TBL] [Abstract][Full Text] [Related]
8. Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells.
Guo Y; Bao C; Ma D; Cao Y; Li Y; Xie Z; Li S
ACS Synth Biol; 2019 Mar; 8(3):482-490. PubMed ID: 30762338
[TBL] [Abstract][Full Text] [Related]
9. SL-scan identifies synthetic lethal interactions in cancer using metabolic networks.
Zangene E; Marashi SA; Montazeri H
Sci Rep; 2023 Sep; 13(1):15763. PubMed ID: 37737478
[TBL] [Abstract][Full Text] [Related]
10. Optimal control nodes in disease-perturbed networks as targets for combination therapy.
Hu Y; Chen CH; Ding YY; Wen X; Wang B; Gao L; Tan K
Nat Commun; 2019 May; 10(1):2180. PubMed ID: 31097707
[TBL] [Abstract][Full Text] [Related]
11. NEXGB: A Network Embedding Framework for Anticancer Drug Combination Prediction.
Meng F; Li F; Liu JX; Shang J; Liu X; Li Y
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077236
[TBL] [Abstract][Full Text] [Related]
12. A deep learning model based on sparse auto-encoder for prioritizing cancer-related genes and drug target combinations.
Chang JW; Ding Y; Tahir Ul Qamar M; Shen Y; Gao J; Chen LL
Carcinogenesis; 2019 Jul; 40(5):624-632. PubMed ID: 30944926
[TBL] [Abstract][Full Text] [Related]
13. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies.
Xu J; Regan-Fendt K; Deng S; Carson WE; Payne PRO; Li F
Pac Symp Biocomput; 2018; 23():92-103. PubMed ID: 29218872
[TBL] [Abstract][Full Text] [Related]
14. TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
Liu Q; Xie L
PLoS Comput Biol; 2021 Feb; 17(2):e1008653. PubMed ID: 33577560
[TBL] [Abstract][Full Text] [Related]
15. Research on Recognition Effect of DSCN Network Structure in Hand-Drawn Sketch.
Ji Q
Comput Intell Neurosci; 2021; 2021():4056454. PubMed ID: 34840560
[TBL] [Abstract][Full Text] [Related]
16. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
[TBL] [Abstract][Full Text] [Related]
17. Ranking novel cancer driving synthetic lethal gene pairs using TCGA data.
Ye H; Zhang X; Chen Y; Liu Q; Wei J
Oncotarget; 2016 Aug; 7(34):55352-55367. PubMed ID: 27438146
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
19. EpiTracer - an algorithm for identifying epicenters in condition-specific biological networks.
Sambaturu N; Mishra M; Chandra N
BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):543. PubMed ID: 27556637
[TBL] [Abstract][Full Text] [Related]
20. SynPathy: Predicting Drug Synergy through Drug-Associated Pathways Using Deep Learning.
Tang YC; Gottlieb A
Mol Cancer Res; 2022 May; 20(5):762-769. PubMed ID: 35046110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
